Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.

Recchia, F; Nuzzo, A; Lalli, A; De Filippis, S; Torchio, P

Recchia, F; Nuzzo, A; Lalli, A; De Filippis, S; Torchio, P.

Affiliation

Recchia F; Division of Internal Medicine (Oncology Unit) Civil Hospital Avezzano, Italy.

Am J Clin Oncol ; 20(2): 166-8, 1997 Apr.

Article in En | MEDLINE | ID: mdl-9124193

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Carcinoma, Ductal, Breast/drug therapy; Adult; Aged; Breast Neoplasms/mortality; Carboplatin/administration & dosage; Carboplatin/adverse effects; Carcinoma, Ductal, Breast/mortality; Cyclophosphamide/administration & dosage; Cyclophosphamide/adverse effects; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Fluorouracil/administration & dosage; Humans; Methotrexate/administration & dosage; Middle Aged; Retreatment/adverse effects; Retreatment/methods; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ductal, Breast / Antibiotics, Antineoplastic Type of study: Guideline Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 1997 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links